Skip to main content
Explore URMC
menu

Judy L. Thompson, Ph.D.

Publications

Showing all 32 journal articles & 1 books available

Journal Articles

2020
Silverstein, S. M.; & Thompson, J. L. "Progress, possibilities, and pitfalls in electroretinography research in psychiatry." Biological Psychiatry. 2020; 87(3): 202-203.

2020
Demmin, D. L.; Netser, R.; Roché, M. W.; Thompson, J. L.; & Silverstein, S. M. "People with current major depression resemble healthy controls on flash electroretinogram indices associated with impairment in people with stabilized schizophrenia". Schizophrenia Research. 2020; 219: 69-76.

2020
Demmin, D. L.; Mote, J.; Beaudette, D. M.; Thompson, J. L.; & Silverstein, S. M. "Retinal functioning and reward processing in schizophrenia". Schizophrenia Research. 2020; 219: 25-33.

2020
Thompson, J. L.; Rosell, D. R.; Slifstein, M.; Xu, X.; Rothstein, E. G.; Modiano, Y. A.; Kegeles, L. S.; Koenigsberg, H. W.; New, A. S.; Hazlett, E. A.; McClure, M. M.; Perez-Rodriguez, M. M.; Siever, L. J.; & Abi-Dargham, A. "Amphetamine-induced striatal dopamine release in schizotypal personality disorder". Psychopharmacology. 2020; in press.

2020
Silverstein, S. M.; Seitz, A. R.; Ahmed, A. O.; Thompson, J. L.; Zemon, V.; Gara, M.; Butler, P. D. "Development and evaluation of a visual remediation intervention for people with schizophrenia". Journal of Psychiatry and Brain Science. 2020; in press.

2017
Butler, P. D.; Thompson, J. L.; Seitz, A. R.; Deveau, J.; & Silverstein, S. M. "Visual perceptual remediation for schizophrenia: rationale, method, and three case studies." Psychiatric Rehabilitation Journal. 2017; 40(1): 43-52.

2017
Mullen, M. G.; Thompson, J. L.; Murphy, A. A.; Malenczak, D.; Giacobbe, G.; Karyczak S.; Holloway, K. E.; Twamley, E. W.; Silverstein, S. M.; & Gill, K. J. "Evaluation of a cognitive remediation intervention for college students with psychiatric conditions." Psychiatric Rehabilitation Journal. 2017; 40(1): 103-107.

2016
Girgis, R. R.; Van Snellenberg, J. X.; Glass, A.; Kegeles, L. S.; Thompson, J. L.; Wall, M.; Cho, R. Y.; Carter, C. S.; Slifstein, M.; Abi-Dargham, A.; & Lieberman, J. A. "A proof-of-concept, randomized controlled trial of DAR-0100A, a dopamine-1 receptor agonist, for cognitive enhancement in schizophrenia." Journal of Psychopharmacology. 2016; 30(5): 428-435.

2015
Silverstein, S. M.; & Thompson, J. L. "A vision science perspective on schizophrenia". Schizophrenia Research: Cognition. 2015; 2: 39-41.

2015
Slifstein, M.; van de Giessen, E.; Van Snellenberg, J.; Thompson, J. L.; Narendran, R.; Gil, R.; Hackett, E.; Girgis, R.; Ojeil, N.; Moore, H.; D'Souza, D.; Malison, R. T.; Huang, Y.; Lim, K.; Nabulsi, N.; Carson, R. E.; Lieberman, J. A.; & Abi-Dargham, A. "Deficits in prefrontal cortical and extra-striatal dopamine release in schizophrenia: A PET fMRI study". JAMA Psychiatry. 2015; 72(4): 316-324.

2015
Van Snellenberg, J. X.; Slifstein, M.; Read, C.; Weber, J.; Thompson, J. L.; Wager, T. D.; Shohamy, D.; Abi-Dargham, A.; & Smith, E. E. "Dynamic shifts in brain network activation during supracapacity working memory task performance". Human Brain Mapping. 2015; 36(4): 1245-64.

2015
Cressman, V. L.; Schobel, S. A.; Steinfeld, S.; Ben-David, S.; Thompson, J. L.; Small, S. A.; Moore, H.; & Corcoran, C. M. "Anhedonia in the psychosis risk syndrome: associations with social impairment and basal orbitofrontal cortical activity". NPJ Schizophrenia. 2015; 1.

2014
van de Giessen, E.; Rosell, D. R.; Thompson, J. L.; Xu, X.; Girgis, R. R.; Ehrlich, Y.; Slifstein, M.; Abi-Dargham, A.; & Siever, L. J. "Serotonin transporter availability in impulsive aggressive personality disordered patients: A PET study with [11C]DASB". Journal of Psychiatric Research. 2014; 58: 147-54.

2014
Thompson, J. L.; Rosell, D. R.; Slifstein, M.; Girgis, R. R.; Xu, X.; Ehrlich, Y.; Kegeles, L. S.; Hazlett, E. A.; Abi-Dargham, A.; & Siever, L. J. "Prefrontal dopamine D1 receptors and working memory in schizotypal personality disorder: A PET study with [11C]NNC112". Psychopharmacology. 2014; 231(21): 4231-40.

2013
Poels, E.M.; Girgis, R. R.; Thompson, J., L.; Slifstein, M.; & Abi-Dargham, A. "In vivo binding of the dopamine-1 receptor PET tracers [11C]NNC112 and [11C]SCH23390: A comparison study in individuals with schizophrenia". Psychopharmacology. 2013; 228(1): 167-74.

2013
Thompson, J. L.; Urban, N.; Slifstein, M.; Xu, X.; Kegeles, L. S.; Girgis, R. R.; Beckerman, Y.; Harkavy-Friedman, J. M.; Gil, R.; & Abi-Dargham, A. "Blunted striatal dopamine release in schizophrenia comorbid with substance dependence". Molecular Psychiatry. 2013; 18(8): 909-15.

2012
Sugranyes, G.; Thompson, J. L.; & Corcoran, C. M. "HPA-axis function, symptoms, and medication exposure in youths at clinical high risk for psychosis". Journal of Psychiatric Research. 2012; 46(11): 1389-93.

2012
Silverstein, S. M.; All, S. D.; Thompson, J. L.; Williams, L. M.; Whitford, T. J.; Nagy, M.; Flynn, G.; Harris, A. W. F.; Galletly, C.; & Gordon, E. "Absolute level of gammy synchrony is increased in first-episode schizophrenia during face processing". Journal of Experimental Psychopathology. 2012; 4: 702-23.

2012
Urban, N. B. L.; Slifstein, M.; Thompson, J. L.; Xu, X.; Girgis, R.; Raheja, S.; Haney, M.; & Abi-Dargham, A. "Dopamine release in chronic cannabis users: a [11C]raclopride positron emission tomography study". Biological Psychiatry. 2012; 71(8): 677-83.

2012
Abi-Dargham, A.; Xu, X.; Thompson, J. L.; Gil, R.; Kegeles, L. S.; Urban, N. B.; Narendran, R.; Hwang, D. R.; Laruelle, M.; & Slifstein, M. "Increased prefrontal cortical D1 receptors in drug naïve patients with schizophrenia: A PET study with [11C]NNC112". Journal of Psychopharmacology. 2012; 26(6): 794-805.

2011
Miyake, N.; Thompson, J.; Skinbjerg, M.; & Abi-Dargham, A. "Presynaptic dopamine in schizophrenia". CNS Neuroscience & Therapeutics. 2011; 17(2): 104-09.

2011
Corcoran, C. M.; Kimhy, D.; Parilla-Escobar, M. A.; Cressman, V. L.; Stanford, A. D.; Thompson, J.; David, S. B.; Crumbley, A.; Schobel, S.; Moore, H.; & Malaspina, D. "The relationship of social function to depressive and negative symptoms in individuals at clinical high risk for psychosis". Psychological Medicine. 2011; 41(2): 251-61.

2010
Rosell, D. R.; Thompson, J. L.; Slifstein, M.; Xu, X.; Frankle, W. G.; New, A. S.; Goodman, M.; Weinstein, S. C.; Laruelle, M.; Abi-Dargham, A.; & Siever, L. J. "Increased 5-HT2A receptor availability in the orbitofrontal cortex of physically aggressive personality disordered patients". Biological Psychiatry. 2010; 67(12): 1154-62.

2010
Kegeles, L.S.; Slifstein, M.; Xu X.; Urban, N.; Thompson, J. L.; Moadel, T.; Harkavy-Friedman, J.M.; Gil, R.; Laruelle, M.; & Abi-Dargham, A. "Striatal and extrastriatal dopamine D2/D3 receptors in schizophrenia evaluated with [18F]fallypride positron emission tomography". Biological Psychiatry. 2010; 68(7): 634-41.

2010
Slifstein, M.; Kegeles, L. S.; Xu, X.; Thompson, J. L.; Urban, N.; Castrillon, J.; Hackett, E.; Bae, S. A.; Laruelle, M.; & Abi-Dargham, A. "Striatal and extrastriatal dopamine release measured with PET and [18F]fallypride". Synapse. 2010; 64(5): 350-62.

2009
Thompson, J. L.; Urban, N.; & Abi-Dargham, A. "How have developments in molecular imaging techniques furthered schizophrenia research?". Imaging in Medicine. 2009; 1(2): 135-153.

2009
Thompson, J. L.; Kelly, M.; Kimhy, D.; Harkavy-Friedman, J. M.; Khan, S.; Messinger, J. W.; Schobel S.; Goetz, R.; Malaspina, D.; & Corcoran, C. "Childhood trauma and psychotic-like symptoms among individuals at clinical high risk for psychosis". Schizophrenia Research. 2009; 108: 176-81.

2008
Corcoran, C.; Kimhy, D.; Stanford, A.; Khan, S.; Walsh, J.; Thompson, J.; Schobel, S.; Harkavy-Friedman, J.; Goetz, R.; Colibazzi, T.; Cressman, V.; & Malaspina, D. "Temporal association of cannabis use with symptoms in individuals at clinical high risk for psychosis". Schizophrenia Research. 2008; 106: 286-93.

2005
Thompson, J. L.; Watson, J. R.; Steinhauer, S. R.; Goldstein, G.; & Pogue-Geile, M. F. "Indicators of genetic liability to schizophrenia: A sibling study of neuropsychological performance". Schizophrenia Bulletin. 2005; 31: 85-96.

2004
Thompson, J. L.; Pogue-Geile, M. F.; & Grace, A. A. "Developmental pathology, dopamine, and stress: A model for the age of onset of schizophrenia symptoms". Schizophrenia Bulletin. 2004; 30: 875-900.

Thompson, J. L.; Holloway, K.; Karyczak, S.; Crandall, D.; Stone, R.; Ellison, M. L.; Gill, K. J.; Davis, M.; & Mullen, M. G. "Services to improve educational and employment outcomes among young people with psychiatric conditions: a systematic review of evaluation studies; under revision.": Under revision.

Beaudette, D. M.; Gold, J. M.; Waltz, J.; Thompson, J. L.; Cherneski, L.; Martin, V.; Monteiro, B.; Cruz, L. N.; Silverstein, S. M. "Predicting attention shaping response in people with schizophrenia". Journal of Psychiatric Research. .

Books & Chapters

2017
Book Title: Helping Youth on the Path to Employment Manual (HYPE)
Author List: Mullen, M.G.; Nemec, P.B.; Sullivan-Soydan, A.P.; Thompson, J.L.; Ellison, M. L.; & Banko, A.B.
Published By: University of MA Medical School, Transitions to Adulthood Research Center2017 in Worcester